Age Acceleration and Mortality Risk Constitute Distinct Dimensions of Organ Aging
By developing multi-omics, organ-specific aging clocks across 14 organs in over 400,000 UK Biobank participants, this study demonstrates that chronological age acceleration and mortality risk represent distinct biological dimensions with separable molecular and genetic architectures, thereby enabling more precise, organ-resolved risk assessments and targeted interventions than conventional single-objective models.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Aging is not a single, uniform process that slows down every part of the body at the same speed. While we all grow older in years, our internal organs deteriorate at different rates and through different biological pathways. Some organs may wear out quickly due to specific diseases, while others remain relatively robust, even in the same person. For decades, scientists have tried to measure this biological wear and tear using "clocks"—mathematical models that estimate how old a person's body really is based on molecular markers in their blood. Traditionally, these clocks have been trained to predict one of two things: how much faster a person is aging compared to their actual years, or how likely they are to die from any cause. However, a new study suggests that these two goals—measuring the speed of aging and measuring the risk of death—are actually tracking two completely different biological realities.
Researchers from the University of Hong Kong, Shanghai Jiao Tong University, and Sun Yat-sen University set out to test whether the biological signals that make an organ age faster are the same as the signals that make it more likely to fail and cause death. They analyzed data from over 400,000 participants in the UK Biobank, a massive medical database. Instead of looking at the body as a whole, they built 14 separate, highly detailed clocks, one for each major organ, including the brain, heart, kidneys, liver, and prostate. To make these clocks as accurate as possible, they did not rely on just one type of data. They combined three different layers of biological information: a catalog of proteins floating in the blood, a list of small molecules involved in metabolism, and standard clinical blood tests. This multi-layered approach allowed them to see a much richer picture of what was happening inside each organ than previous studies could.
The team trained each of these 14 organ clocks in three different ways. The first type tried to predict how much faster an organ was aging compared to a person's actual age. The second type was trained to predict death specifically caused by problems with that organ, such as kidney failure for the kidney clock or heart failure for the heart clock. The third type was trained to predict death from any cause whatsoever, regardless of which organ was responsible. By comparing the results of these three different training methods, the researchers discovered a fundamental split. The clocks trained to predict death from a specific organ were very different from the clocks trained to predict general aging speed. In fact, they found that an organ could be aging rapidly without necessarily being on the brink of causing death, and conversely, an organ could be carrying a high risk of causing death without showing the classic signs of rapid aging.
This distinction became most clear when the researchers looked at the prostate. In previous studies that used "all-cause" death as the training goal, the aging signals for the prostate were almost invisible. This is because prostate cancer, while common, accounts for a relatively small percentage of total deaths compared to heart disease or stroke. When a model is trained to predict death from any cause, the strong signals from the most common killers drown out the weaker signals from less common causes. However, when the researchers trained a clock specifically to look for prostate-related deaths, a powerful signal emerged. This specific clock could strongly predict the development of prostate cancer, whereas the general "all-cause" clock failed to see it entirely. This phenomenon, which the authors call the "prostate paradox," proved that using a single, general goal to train aging models hides vital, organ-specific dangers.
The study also revealed that the genetic instructions behind these two types of aging are distinct. The researchers scanned the DNA of the participants to find which genes were linked to rapid aging versus which genes were linked to organ-specific death. They found that the genes driving an organ to age quickly were largely different from the genes that made that organ likely to cause death. For example, variations in genes related to fat and lipid metabolism were strongly tied to how fast an organ aged, while genes associated with specific organ failure, such as those involved in immune response or protein secretion, were tied to the risk of death. This means that the biological machinery responsible for the slow, steady wear and tear of aging is not the same machinery that triggers a fatal organ failure.
By separating these two dimensions, the researchers were able to identify specific biological markers that act as early warning systems for organ failure. They found that certain proteins in the blood, such as GDF15, which signals cellular stress, and NPPB, which relates to heart function, were key indicators of mortality risk. These markers were often missed by models that only looked at general aging. The study also showed that these organ-specific risks could be predicted using genetic scores alone, even without measuring the proteins or metabolites in the blood. This suggests that in the future, doctors might be able to use a simple genetic test to identify which specific organs in a patient are at high risk of failing, long before any symptoms appear.
The findings challenge the long-held view that aging is a single, unified process that can be measured with one number. Instead, the body appears to be a collection of distinct systems, each with its own timeline and its own set of risks. An organ might be aging slowly but still be vulnerable to a sudden, fatal failure, or it might be aging rapidly but remain stable for a long time. The study concludes that to truly understand and prevent age-related diseases, we must stop treating the body as a single unit and start looking at the specific, independent aging trajectories of each organ. This approach allows for a more precise kind of medicine, where interventions can be targeted at the specific organ that is at risk, rather than applying a one-size-fits-all strategy to the entire body.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.